248 related articles for article (PubMed ID: 26169957)
1. The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications.
Cotecchia S; Del Vescovo CD; Colella M; Caso S; Diviani D
Cell Signal; 2015 Oct; 27(10):1984-93. PubMed ID: 26169957
[TBL] [Abstract][Full Text] [Related]
2. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy.
Appert-Collin A; Cotecchia S; Nenniger-Tosato M; Pedrazzini T; Diviani D
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10140-5. PubMed ID: 17537920
[TBL] [Abstract][Full Text] [Related]
3. Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance.
O'Connell TD; Jensen BC; Baker AJ; Simpson PC
Pharmacol Rev; 2014; 66(1):308-33. PubMed ID: 24368739
[TBL] [Abstract][Full Text] [Related]
4. The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse.
O'Connell TD; Ishizaka S; Nakamura A; Swigart PM; Rodrigo MC; Simpson GL; Cotecchia S; Rokosh DG; Grossman W; Foster E; Simpson PC
J Clin Invest; 2003 Jun; 111(11):1783-91. PubMed ID: 12782680
[TBL] [Abstract][Full Text] [Related]
5. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
Balakumar P; Jagadeesh G
Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
[TBL] [Abstract][Full Text] [Related]
6. Cardiac 7-transmembrane-spanning domain receptor portfolios: diversify, diversify, diversify.
Liggett SB
J Clin Invest; 2006 Apr; 116(4):875-7. PubMed ID: 16585959
[TBL] [Abstract][Full Text] [Related]
7. Cardiac alpha 1-adrenergic drive in pathological remodelling.
Woodcock EA; Du XJ; Reichelt ME; Graham RM
Cardiovasc Res; 2008 Feb; 77(3):452-62. PubMed ID: 18032391
[TBL] [Abstract][Full Text] [Related]
8. Subcellular compartmentalization of proximal Gα
Dahl EF; Wu SC; Healy CL; Harsch BA; Shearer GC; O'Connell TD
J Biol Chem; 2018 Jun; 293(23):8734-8749. PubMed ID: 29610273
[TBL] [Abstract][Full Text] [Related]
9. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes.
Zou MX; Roy AA; Zhao Q; Kirshenbaum LA; Karmazyn M; Chidiac P
Cell Signal; 2006 Oct; 18(10):1655-63. PubMed ID: 16517124
[TBL] [Abstract][Full Text] [Related]
10. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the cell-surface targeting and function of beta- and alpha1-adrenergic receptors by Rab1 GTPase in cardiac myocytes.
Filipeanu CM; Zhou F; Fugetta EK; Wu G
Mol Pharmacol; 2006 May; 69(5):1571-8. PubMed ID: 16461589
[TBL] [Abstract][Full Text] [Related]
12. MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by α1-adrenergic receptors.
Ogata T; Naito D; Nakanishi N; Hayashi YK; Taniguchi T; Miyagawa K; Hamaoka T; Maruyama N; Matoba S; Ikeda K; Yamada H; Oh H; Ueyama T
Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3811-6. PubMed ID: 24567387
[TBL] [Abstract][Full Text] [Related]
13. An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes.
Huang Y; Wright CD; Merkwan CL; Baye NL; Liang Q; Simpson PC; O'Connell TD
Circulation; 2007 Feb; 115(6):763-72. PubMed ID: 17283256
[TBL] [Abstract][Full Text] [Related]
14. Differential Activation of P-TEFb Complexes in the Development of Cardiomyocyte Hypertrophy following Activation of Distinct G Protein-Coupled Receptors.
Martin RD; Sun Y; MacKinnon S; Cuccia L; Pagé V; Hébert TE; Tanny JC
Mol Cell Biol; 2020 Jun; 40(14):. PubMed ID: 32341082
[TBL] [Abstract][Full Text] [Related]
15. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
[TBL] [Abstract][Full Text] [Related]
16. A novel player in cellular hypertrophy: Giβγ/PI3K-dependent activation of the RacGEF TIAM-1 is required for α₁-adrenoceptor induced hypertrophy in neonatal rat cardiomyocytes.
Vettel C; Wittig K; Vogt A; Wuertz CM; El-Armouche A; Lutz S; Wieland T
J Mol Cell Cardiol; 2012 Aug; 53(2):165-75. PubMed ID: 22564263
[TBL] [Abstract][Full Text] [Related]
17. The zinc finger-only protein Zfp260 is a novel cardiac regulator and a nuclear effector of alpha1-adrenergic signaling.
Debrus S; Rahbani L; Marttila M; Delorme B; Paradis P; Nemer M
Mol Cell Biol; 2005 Oct; 25(19):8669-82. PubMed ID: 16166646
[TBL] [Abstract][Full Text] [Related]
18. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
[TBL] [Abstract][Full Text] [Related]
19. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
[TBL] [Abstract][Full Text] [Related]
20. Myocyte adrenoceptor signaling pathways.
Xiang Y; Kobilka BK
Science; 2003 Jun; 300(5625):1530-2. PubMed ID: 12791980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
